Fact.MR, a Market Research and Competitive Intelligence Provider - As per industry analysis on vancomycin by Fact.MR, a market research and competitive intelligence provider, the global market is predicted to expand at a CAGR of 5.8% over the forecast period and reach US$ 465.1 Million by 2027.
The U.S. Vancomycin Market Was Valued At US$ 84.5 Million In 2020 And Is Anticipated To Rise At The Highest CAGR Over The Forecast Period.
Healthcare beneficiaries play a key part in the movement, influencing corporations to develop pharmaceuticals for comprehensive treatment. Rising initiatives by government organizations for the development of novel drugs and treatments are supporting vancomycin market growth
Fact.MR, a Market Research and Competitive Intelligence Provider - As per industry analysis on vancomycin by Fact.MR, a market research and competitive intelligence provider, the global market is predicted to expand at a CAGR of 5.8% over the forecast period and reach US$ 465.1 Million by 2027.
The human body is home to a wide range of microorganisms. Staphylococcus aureus, a gram-positive bacterium that is most typically found on the human skin and nasal passages, is one of them. The market for vancomycin is developing due to increasing prevalence of this infection. Increasing government and non-government awareness campaigns are also expected to contribute to market growth.
Want A Detailed Understanding of Vancomycin Market? Request for a Sample Here
https://www.factmr.com/connectus/sample?flag=S&rep_id=7293
The global vancomycin market is being driven by increased incidence of diseases caused by vancomycin-resistant Staphylococcus aureus (VRSA), and poor sanitation, which, in turn, increases the risk of hospital-acquired infections.
VRSA infections can be treated with a range of commercially available drugs, but maintaining basic sanitary conditions, including wound care, hand washing before and after direct contact with patients, and the use of disposable gloves, is the most effective strategy for preventing the spread of VRSA.
Vancomycin is used as a first-line and second-line treatment, depending on the diseases for which it is prescribed. The global market for vancomycin is predicted to rise over the next years owing to increasing demand for antibiotics. The market is reliant on the number of processed prescriptions for cases, which is increasing at an unprecedented rate.
Key Takeaways from Vancomycin Market Study
- Global vancomycin market to reach US$ 465.1 valuation Mn by 2027.
- Market in Germany projected to rise at a CAGR of 4% over the forecast period.
- Market in Canada to record 4.6% CAGR over the forecast period of 2021-2027.
- China vancomycin market forecast to reach size of US$ 102.3 Mn by 2027.
What Might Restrain Demand for Vancomycin to Some Extent?
“Rising Use of Generic Alternatives & Certain Side Effects Hampering Market Value”
Two typical adverse drug reactions associated with IV vancomycin are severe local pain and thrombophlebitis (which affect about 1% of patients). Clinical experiments conducted in the mid-1950s revealed that early impure versions of vancomycin tablets caused kidney damage (nephrotoxicity) and hearing loss (ototoxicity). Nephrotoxicity was discovered to be a rare adverse effect in later investigations using purer forms of vancomycin (0.1% to 1% of patients).
Certain limitations, such as rising use of generic alternatives, particularly as patents expire, and short lifecycle of medications, are expected to hinder vancomycin market growth.
To gain in-depth Insights on Vancomycin Market Report, Request Methodology at
https://www.factmr.com/connectus/sample?flag=AE&rep_id=7293
Winning Strategy
To increase their market position across geographies, vancomycin suppliers are investing in the research and development of new medicines. Key players are also working hard to secure regulatory approvals for their products.
For instance,
- In 2019, Rutgers University researchers identified two genes that make illnesses such as VRSA resistant to therapy.
More Valuable Insights on Offer
Fact.MR, in its new offering, presents an unbiased analysis of the global vancomycin market, presenting historical demand data (2017-2020) and forecast statistics for the period of 2021-2027.
The study divulges essential insights on the market on the basis of type (daptomycin, linezolid, quinupristin, ampicillin, chloramphenicol, and others) and application (sepsis, lung infection, skin soft tissue infection, colitis & intestinal inflammation, and other infections), across five major regions (North America, Europe, Asia Pacific, Latin America, and MEA).
Fact.MR’s Domain Expertise in Healthcare Sector
Our healthcare consulting team guides organizations at each step of their business strategy by helping you understand how the latest influencers account for operational and strategic transformation in the healthcare sector. Our expertise in recognizing the challenges and trends impacting the global healthcare industry provides indispensable insights and support - encasing a strategic perspective that helps you identify critical issues and devise appropriate solutions.
Hyperbaric Oxygen Therapy Devices Market- The global hyperbaric oxygen therapy devices market reached a valuation of US$ 3.1 Bn in 2020. Sales of hyperbaric oxygen therapy devices are slated to rise at a CAGR of 8.9% to reach US$ 7.3 Bn by the end of 2028, with North America remaining the most lucrative regional market.
Oncology Biosimilars Market- The market for oncology biosimilars is anticipated to surge up at an astronomical pace, registering a CAGR of 11% during the forecast period from, and 2022 to 2032. As of 2021, the market was valued at US$ 4 Billion, and is likely to rise at a Y-o-Y growth rate of 5% in 2022 to reach US$ 4.2 Billion.
Mycoplasma Detection Systems Market- The global mycoplasma detection systems market is likely to be valued at US$ 600 Million in FY 2022, up from US$ 560 Million in 2021. During the past year, the industry registered a Y-o-Y increase worth 7.1%.
Heart Valve Devices Market- The global heart valve devices market is likely to be valued at US$ 11.16 Billion in FY 2022, up from US$ 9.85 Billion in 2021. During the past year, the industry registered a Y-o-Y increase worth 13.3%. From 2022 to 2032, heart valve devices sales are poised to flourish at a CAGR of 13% to reach a value of US$ 37.5 Billion by the end of 2032.
Medical Device Technologies Market- Demand for medical device technologies was valued at US$ 470.32 Billion in 2021, and is likely to flourish at a Y-o-Y expansion rate of 4.6% in 2022, reaching US$ 491.95 Billion. From 2022-2032, the industry is poised to experience a CAGR of 3%, anticipated to close at a valuation of US$ 663 Billion.
Ocular Drug Delivery Technology Market- The global ocular drug delivery technology market is likely to be valued at US$ 17.74 Billion in FY 2022, up from US$ 16.4 Billion in 2021. During the past year, the industry registered a Y-o-Y increase worth 8.2%. From 2022 to 2032, the ocular drug delivery technology industry is poised to flourish at a CAGR of 8.2% to reach a value of US$ 39 Billion by the end of 2032.
Swab Sticks Market- Global sales of swab sticks are estimated to be valued at US$ 1.79 Bn in 2022. Looking ahead, the global swab sticks market is predicted to reach US$ 3.24 Bn by 2032, expanding at a CAGR of 6.1% from 2022 to 2032.
Sepsis Diagnostics Market- The market is being driven primarily by rising demand for assays and reagents across regions. As of 2021, the industry was valued at US$ 690 Million, and witnessed a Y-o-Y expansion of 9.4% in 2022 to be valued at US$ 755 Million. By 2032, the market is poised to reach US$ 1,630 Million.
Oligonucleotide Synthesis Market- The global oligonucleotide synthesis market is likely to be valued at US$ 5.7 Billion in FY 2022, up from US$ 5.2 Billion in 2021. During the past year, the industry registered a Y-o-Y increase worth 9.6%. From 2022 to 2032, oligonucleotide synthesis demand is poised to flourish at a CAGR of 11.5% to reach a value of US$ 17 Billion by the end of 2032.
Biomarkers Market- The global sales of Biomarkers in 2021 was held at US$ 59.1 Bn. With 15.3%, the projected market growth during 2022 - 2032 is expected to be significantly higher than the historical growth. Safety Biomarkers are expected to be the highest revenue generating biomarker type, with a projected growth of 15.9% during 2022 – 2032.
About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
Mahendra Singh
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
Email: sales@factmr.com
Tel: +1 (628) 251-1583